15th Annual AUA Urology Practice Management Conference (2018)

May 17, 2018 to May 18, 2018

Due to continuous legislative, regulatory and coding changes practice managers and urologists lack the knowledge required to implement changes to their practice.

Target Audience

This activity is designed for:

  • Urologists
  • Practice Managers
  • Advanced Practice Providers

Learning Objectives

After completing this activity, participants will be able to:

1.    Improve your practice's ability to adapt to changing business strategies
2.    Develop tools to assist with efficient practice operations
3.    Cultivate patient and referral source loyalty
4.    Optimize revenue from patient services
5.    Exchange ideas with peers about the latest urology management hot topics.

Course summary
Available credit: 
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Non-Physician Participation
Course opens: 
05/17/2018
Course expires: 
05/18/2021
Event starts: 
05/17/2018 - 7:00am
Event ends: 
05/18/2018 - 4:00pm
Rating: 
0

Day One


7:00-8:00am Registration & Continental Breakfast with Exhibitors 

8:00-9:30am Maintaining Independence as a Practice………………………… Max Reiboldt 

9:30-10:30am Moving from Volume to Value – Determining The Cost of Care…………………. Neil Baum, MD 

10:30-11:30am Urology Coding - Coding Challenges for 2018……………………………………………. Edna Maldonado 

11:30am-12:00 Exhibit Break 

12:00-1:30pm Luncheon 

1:30-2:20pm Session # 1 - Choose 1 of the following 4 sessions 

Masters Track– Principals of Patient Engagement and Satisfaction …… Ellis Knight, MD 
Financial Track– Nuts & Bolts of Effective Practice Operations……… Jay Motola, MD 
Physician Track- How to Best On-Board your Physician...............Nicole Jenkins 
Management Track- Utilizing Benchmarking for your Practice……… John O’Connor 

2:30-3:20pm Session # 2 - Choose 1 of the following 4 sessions 

Masters Track– USP800 Regulation –What you Need to Know…….… Dan Schonwald 
Financial Track– Effective Financial Operations for your Practice........... Jeff Gorke 
Physician Track- Best Practices for Contract Negotiations.... Max Reiboldt 
Management Track– Improve Practice Management through Participating in AQUA Registry… Matthew Cooperberg MD, 
Steve Schlossberg MD, Ronald Suh MD, Felice Washington 

3:30-4:00pm Exhibit Break 

4:00-5:30pm Information and Technology Lightning Rounds 
Short Discussions about Several Important Topics..................... Jeffery Daigrepont
Round 1- Beyond EHRs – (Future IT Trends, Gadgets, Predictions and Speculation) 
Round 2- ePatient Communications (How to Securely Communicate with Patients) 
Round 3- Vendor Contracting (Strategies for Negotiating New Contacts and Existing Ones)
Round 4- Key System Requirements to Support Value Based Reimbursement 

5:30-6:15pm Networking Reception 

Day Two


7:00-8:00am Registration & Continental Breakfast with Exhibitors 

8:00-9:00am Government and Regulatory Update............................. Thomas Rechtschaffen, MD 

9:00-10:00am MACRA Update – What your Practice Needs to Know………. Franklin Gaylis, MD 

10:00-11:00am Effective Integration of APP’s in Urology……Brooke Zilinskas PA, Tricia Zubert NP, Jody Purifoy NP, Anne 
Calvaresi CRNP 

11:00-11:30am Exhibit Break 

11:30-12:30pm Luncheon 

Current Hot Topic Discussion-Join fellow attendees in a live forum to discuss the matters that are impacting 
your practice. Whether you’re from a solo practice, a medium or large- sized urology group, or even a hospital 
or academic practice, there’s a discussion group to meet your needs. 

12:30-1:20pm Choose 1 of the following 4 sessions 

Hospital / Academic Owned Practices
Independent Small Urology Practices (1-5 Providers) 
Independent Medium Urology Practices (6-19 Providers) 
Independent Large Urology Practices (20+ Providers) 

1:30-2:20pm Choose 1 of the following 4 sessions 

Hospital / Academic Owned Practices
Independent Small Urology Practices (1-5 Providers) 
Independent Medium Urology Practices (6-19 Providers) 
Independent Large Urology Practices (20+ Providers) 

2:30-4:00pm Building and Maintaining Risk Management and Compliance Programs for your Organization ………. Sean Weiss 

San Francisco, CA
United States

Faculty and Disclosures

Planner Disclosures:

  • Victor Nitti, MD - Serenity Pharmaceuticals Self Yes Investment Interest 01/09/2012 Present
  • Brant Inman, MD - Combat Medical Self Yes Consultant or Advisor 02/01/2016 Present

Speaker Disclosures

  • Neil Baum, MD – Meeting participant or lecturer with Coloplast, Watson, Eli Lilly, Ferring – Consultant with NeoTract, and Reel Health Network.
  • Matthew Cooperberg – Consultant with Dendreon, Myriad Genetics, MDx Health, and Astellas – Meeting participant or lecturer with GenomeDx.
  • Jeffrey Daigrepont – Meeting participant or lecturer with The Coker Group.
  • Franklin Gaylis, MD – Owner, Product Development of GenIT LLC – Scientific Study or Trial with Astellas, Janssen Pharmaceuticals, and Bayer Pharmaceuticals – Consultant with Specialty Networks LLC.
  • Ellis Knight, MD – Employee with Coker Group.
  • Jay Motola, MD – Investment Interest with Allied Urological/Metropolitan Lithotripsy – Consultant and Meeting participant or lecturer with Healthtronics.
  • Thomas Rechtschaffen, MD – Meeting Participant or lecturer with Astellas Pharmaceuticals US.
  • Max Reiboldt – Leadership position, consultant, and employee with The Coker Group.
  • Daniel Schonwald – Consultant with Vital Source GPO, Dendreon, and Integra Connect.
  • Ronald Suh – Owner of Surgical Data Solutions, LLC – Scientific study or trial with Ferring Pharmaceuticals, Atellas, Bayer Pharmaceuticals, and Medivation/Pfizer – Meeting participant or lecturer with Endo Pharmaceutical.
  • Brooke Zilinskas, PA – Leadership position and meeting participant or lecturer with Urology Association of Physician Assistant

The following individuals had no disclosures to report:

  • Anne Calvaresi, CRNP
  • Rebecca Durham
  • Jeff Gorke
  • Nicole Jenkins
  • Edna Maldonado, CPC
  • Jody Purifoy, DNP, APRN, CNP
  • Steven Schlossberg
  • Sean Weiss
  • Tricia Zubert, NP

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Non-Physician Participation

Accreditation Period

Course opens: 
05/17/2018
Course expires: 
05/18/2021
Please login or register to take this course.